BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Lucas Ward does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 SXTP60 Degrees Pharmaceuticals, Inc. Common Stock | Buy | $7.00 | Jun 2025 | −99.4% | Miss |
 VVOSVivos Therapeutics Inc | Buy | $6.20 | Apr 2025 | −39.7% | Hit |
 LIQTLiqTech International Inc | Buy | $3.40 | Apr 2025 | −38.4% | Miss |
 HSCSHeart Test Laboratories Inc. Common Stock | Buy | $14.00 | Mar 2025 | −16.8% | Miss |
| LIQTLiqTech International Inc | Buy | $3.20 | Nov 2024 | +12.4% | Hit |
| VVOSVivos Therapeutics Inc | Buy | $6.60 | Nov 2024 | −35.1% | Hit |
| HSCSHeart Test Laboratories Inc. Common Stock | Buy | $15.00 | Sep 2024 | −5.5% | Miss |
| LIQTLiqTech International Inc | Buy | $5.15 | Aug 2024 | −53.2% | Miss |
 ACONAclarion Inc | Buy | $1.50 | Aug 2024 | −89.2% | Miss |
| VVOSVivos Therapeutics Inc | Buy | $6.60 | Aug 2024 | +55.2% | Hit |
 VMARVision Marine Technologies Inc | Buy | $2.00 | Jul 2024 | −121.7% | Miss |
| ACONAclarion Inc | Buy | $1.60 | Jul 2024 | −90.8% | Miss |
| LIQTLiqTech International Inc | Buy | $5.15 | Feb 2024 | −66.5% | Miss |
| VMARVision Marine Technologies Inc | Buy | $4.50 | Oct 2023 | −131.2% | Miss |
| SXTP60 Degrees Pharmaceuticals, Inc. Common Stock | Buy | $2.40 | Oct 2023 | −109.0% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.